|
WO2008003826A1
|
|
Novel genes and markers in essential arterial hypertension
|
|
US2007213274A1
|
|
Novel genes and markers associated with high-density lipoprotein-cholesterol (HDL-C)
|
|
WO2007006858A2
|
|
Method for treatment of cardiovascular and metabolic diseases and detecting the risk of the same
|
|
WO2006053955A2
|
|
Method and kit for detecting a risk of essential arterial hypertension
|
|
US2007015170A1
|
|
Method and kit for detecting a risk of coronary heart disease
|
|
US2006110751A1
|
|
Method and kit for detecting a risk of essential arterial hypertension
|
|
WO2006008342A1
|
|
Method for detecting the risk of and for treatment of type 2 diabetes
|
|
FI20050043A0
|
|
Procedure for detecting the risk of coronary disease and acute myocardial infarction
|
|
FI20041340A0
|
|
Procedure and test package for detecting the risk of a sudden heart attack
|
|
FI20040255A0
|
|
A method for detecting the risk of pre-eclampsia
|
|
FI20040227A0
|
|
Procedure for detecting the risk of cancer, coronary heart disease and cerebral palsy
|
|
FI20040052A0
|
|
A method for detecting the risk of acute myocardial infarction and coronary heart disease
|
|
AU2003216772A1
|
|
Nucleic acid molecule encoding a variant ddah 1 protein and uses thereof
|
|
EP1463826A1
|
|
Method for assessing the risk of cardiovascular disease
|
|
FI20022178A0
|
|
Procedure and reagent packaging to detect the risk of diabetes
|
|
FI20021783A0
|
|
Procedure for detecting the risk of cardiovascular disease
|
|
FI20011169A0
|
|
Procedure for modifying pine bark
|
|
US6740746B2
|
|
DNA molecule encoding a variant paraoxonase and uses thereof
|
|
FI20010331A0
|
|
A method of treating hypertension and coronary and cerebrovascular disease
|
|
FI20010323A0
|
|
Procedure for detecting a risk of elevated blood pressure and its uses
|
